October 5 (SeeNews) - Bulgarian blue-chip drug maker Sopharma said it posted a 7.0% increase in total sales in the nine months through September.
The company provide no sales figures.
Domestic sales picked up by 10% through September while sales abroad rose 5.0%, the company said in a filing with the X3news service of the Bulgarian Stock Exchange on Friday.
In September, Sopharma's total sales went up by an annual 3.0% with domestic sales growing by a hefty 37% and sales abroad climbing 6.0%, the statement said. In August, the drug maker recorded a 6.0% annual increase in total sales with domestic sales down 3.0% and exports up 9.0%.
Sopharma's consolidated net profit rose by 76.5% on the year to 20.39 million levs ($15.24 million/10.4 million euro) in the first half of 2009 on sales of 225.8 million levs.
Sopharma (www.sopharma.bg) exports to 28 countries with Russia and other former Soviet republics as its main markets abroad.
The company's shares were trading down 0.72% at 4.13 levs by 0944 GMT on the Sofia bourse on Monday.
(1 euro=1.95583 Bulgarian levs)